High Susanna Gatti

Dyne Therapeutics, Inc. · Chief Operating Officer

High Susanna Gatti is listed in filings as Chief Operating Officer at Dyne Therapeutics, Inc.. This profile follows SEC Form 4 activity through Sep 19, 2024, including sale activity. Recent filings connect the profile to Dyne Therapeutics, Inc. (DYN). The current snapshot covers public activity from Jun 11, 2024 to Sep 19, 2024. Reported amounts are shown as $91.0K to $2.4M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceLast Price
Dyne Therapeutics, Inc.DYN$91k2.9k sharesSellJun 11, 2024$31.23$22.72
Dyne Therapeutics, Inc.DYN$74k2.4k sharesSellJun 11, 2024$31.23$22.72
Dyne Therapeutics, Inc.DYN$2M80k sharesSellJun 10, 2024$30.24$22.72
Dyne Therapeutics, Inc.DYN$471k14k sharesSellJun 12, 2024$33.70$22.72
Dyne Therapeutics, Inc.DYN$864k26k sharesSellJun 12, 2024$33.17$22.72
Dyne Therapeutics, Inc.DYN$1M29.8k sharesSellJun 21, 2024$35.01$22.72
Dyne Therapeutics, Inc.DYN$359k10.2k sharesSellJun 24, 2024$35.33$22.72
Dyne Therapeutics, Inc.DYN$15k328 sharesSellAug 19, 2024$46.00$22.72
Dyne Therapeutics, Inc.DYN$116k2.6k sharesSellAug 19, 2024$45.01$22.72
Dyne Therapeutics, Inc.DYN$87k2.7k sharesSellSep 11, 2024$31.89$22.72
Dyne Therapeutics, Inc.DYN$81k2.5k sharesSellSep 11, 2024$31.89$22.72